Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver Failure
Babak J. Orandi(University of Alabama at Birmingham), Catherine Dillon, James Hanje(The Ohio State University), Jodi Olson, Nahid Attar, Jayme E. Locke(New York University), Raymond T. Chung(Harvard University), Brendan M. McGuire(University of Alabama at Birmingham), Natalie Murray(Institute of Genetics), Adrian Reuben(Medical University of South Carolina), Wenle Zhao(Medical University of South Carolina), Andrés T. Blei(Northwestern University), K. Rajender Reddy(Hospital of the University of Pennsylvania), Tarek Hassanein, Timothy M. McCashland(University of Nebraska–Lincoln), Linda S. Hynan(The University of Texas Southwestern Medical Center), Constantine Karvellas(University of Alberta), Corron Sanders, R. Todd Stravitz, Robert J. Fontana(University of Michigan), Daniel Ganger(Northwestern University), Michael L. Schilsky(Yale University), Cora E. Lewis(Northwestern University), William M. Lee(The University of Texas Southwestern Medical Center), Norah M. Terrault(University of Southern California), Bilal Hameed(University of California, San Francisco), Edwin Harrison, Paul A. MacLennan(University of Alabama at Birmingham), Lorenzo Rossaro(University of California Davis Medical Center), Ram Subramanian, Carla Pezzia, Chandler McLeod(University of Alabama at Birmingham), Oren K. Fix(Swedish Medical Center), Valerie Durkalski, Roert Brown, Anne M. Larson(University of Washington), Obaid S. Shaikh(University of Pittsburgh), Santiago J. Muñoz(Einstein Medical Center Philadelphia), Alastair D. Smith(Duke Medical Center), Exmina Lalani, J. Eileen Hay(Mayo Clinic in Arizona), Steven Han, Atif Zaman, Iris Liou(University of Washington), Grace Samuel, Jaime L. Speiser(Wake Forest University), Raj Satyanarayana(Jacksonville College), Jeffrey S. Crippin(Washington University in St. Louis)
Cited by 27
Related Papers
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Liver biopsy†
|Hepatology|2008|1.9k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
|Diabetes Care|2007|1.5k
Connecting copper and cancer: from transition metal signalling to metalloplasia
|Nature reviews. Cancer|2021|1.3k